Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Case report: coma due to oxytetracycline.

R T Jung, C A Rowntree

    Current Medical Research and Opinion
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Oxytetracycline, an antibiotic, may cause gradual-onset coma as a rare side effect. Patients may experience confusion and hallucinations post-recovery, highlighting the need for vigilance.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS).

    Clinical endocrinology·2007
    Same author

    Optimisation of thyroid hormone replacement using an automated thyroid register.

    International journal of clinical practice·2006
    Same author

    Mortality and vascular outcomes in patients treated for thyroid dysfunction.

    The Journal of clinical endocrinology and metabolism·2006
    Same author

    Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology.

    Diabetic medicine : a journal of the British Diabetic Association·2005
    Same author

    Does an automated thyroid register improve the clinical management of hypothyroid patients? An observational study.

    Clinical endocrinology·2005
    Same author

    QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests.

    Heart (British Cardiac Society)·2004
    Same journal

    Treatment patterns among pediatric and adult patients with ulcerative colitis in the United States: a retrospective cohort study.

    Current medical research and opinion·2026
    Same journal

    Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Jordan: epidemiology, trends, determinants, and clinical outcomes.

    Current medical research and opinion·2026
    Same journal

    RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024-2025 RSV season survey.

    Current medical research and opinion·2026
    Same journal

    Clinical and healthcare resource utilization outcomes following revision knee arthroplasty with and without a gradually reducing radius revision knee system.

    Current medical research and opinion·2026
    Same journal

    Medication adherence measurement methods and their reported relationship with medication safety outcomes: a scoping review.

    Current medical research and opinion·2026
    Same journal

    BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia.

    Current medical research and opinion·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Neurology
    • Internal Medicine

    Background:

    • Oxytetracycline is a broad-spectrum antibiotic commonly prescribed for various bacterial infections.
    • Neurological side effects associated with antibiotic use, while uncommon, necessitate careful monitoring.

    Observation:

    • A 67-year-old female patient developed a coma of gradual onset during treatment with oxytetracycline.
    • The patient's neurological status significantly declined, leading to a comatose state.

    Findings:

    • The patient regained consciousness approximately 10 hours after the final dose of oxytetracycline.
    • Following regaining consciousness, the patient exhibited persistent confusion and hallucinations for 24 hours.

    Implications:

    Related Experiment Videos

    • This case underscores the potential for oxytetracycline to induce severe neurological adverse events, including coma.
    • Clinicians should consider oxytetracycline toxicity in patients presenting with unexplained coma during antibiotic therapy.
    • Awareness of these potential side effects is crucial for timely diagnosis and management.